Candriam S.C.A. Zai Lab LTD Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
A detailed history of Candriam S.C.A. transactions in Zai Lab LTD stock. As of the latest transaction made, Candriam S.C.A. holds 390,023 shares of ZLAB stock, worth $11 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
390,023
Previous 365,013
6.85%
Holding current value
$11 Million
Previous $6.33 Million
48.85%
% of portfolio
0.06%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding ZLAB
# of Institutions
121Shares Held
46.7MCall Options Held
223KPut Options Held
588K-
Janus Henderson Group PLC London, X08.76MShares$246 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA8.44MShares$237 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA6.44MShares$181 Million0.02% of portfolio
-
Viking Global Investors LP1.95MShares$54.9 Million0.18% of portfolio
-
Bamco Inc New York, NY1.91MShares$53.6 Million0.13% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.75B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...